The management of atrial fibrillation in heart failure

Rupa Bala, David J. Callans

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The development of atrial fibrillation (AF) can greatly complicate the course of heart failure (HF). Although recent trials have indicated the nonsuperiority of a rhythm control strategy in the general population with AF, this may not apply to patients with HF. We feel strongly that AF be treated aggressively in patients with HF, defaulting toward an initial rhythm control strategy, to avoid the hemodynamic detriment of irregular rapid ventricular response and the development of tachycardia-related myopathy. The index episode is treated with cardioversion and antiarrhythmic therapy. If significant benefit is demonstrated, the rhythm control strategy is maintained, to the point of catheter ablation for AF if necessary. If there is no change in cardiac performance or symptoms after cardioversion, strict rate control is enforced, to the point of atrioventricular node ablation and pacing if necessary.

Original languageEnglish (US)
Pages (from-to)325-333
Number of pages9
JournalCurrent Treatment Options in Cardiovascular Medicine
Volume8
Issue number4
DOIs
StatePublished - 2006
Externally publishedYes

Fingerprint

Atrial Fibrillation
Heart Failure
Electric Countershock
Atrioventricular Node
Catheter Ablation
Muscular Diseases
Tachycardia
Hemodynamics
Population
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The management of atrial fibrillation in heart failure. / Bala, Rupa; Callans, David J.

In: Current Treatment Options in Cardiovascular Medicine, Vol. 8, No. 4, 2006, p. 325-333.

Research output: Contribution to journalArticle

@article{4a0fa51ad5ef4ad683971c82dd40462f,
title = "The management of atrial fibrillation in heart failure",
abstract = "The development of atrial fibrillation (AF) can greatly complicate the course of heart failure (HF). Although recent trials have indicated the nonsuperiority of a rhythm control strategy in the general population with AF, this may not apply to patients with HF. We feel strongly that AF be treated aggressively in patients with HF, defaulting toward an initial rhythm control strategy, to avoid the hemodynamic detriment of irregular rapid ventricular response and the development of tachycardia-related myopathy. The index episode is treated with cardioversion and antiarrhythmic therapy. If significant benefit is demonstrated, the rhythm control strategy is maintained, to the point of catheter ablation for AF if necessary. If there is no change in cardiac performance or symptoms after cardioversion, strict rate control is enforced, to the point of atrioventricular node ablation and pacing if necessary.",
author = "Rupa Bala and Callans, {David J.}",
year = "2006",
doi = "10.1007/s11936-006-0053-3",
language = "English (US)",
volume = "8",
pages = "325--333",
journal = "Current Treatment Options in Cardiovascular Medicine",
issn = "1092-8464",
publisher = "Current Science, Inc.",
number = "4",

}

TY - JOUR

T1 - The management of atrial fibrillation in heart failure

AU - Bala, Rupa

AU - Callans, David J.

PY - 2006

Y1 - 2006

N2 - The development of atrial fibrillation (AF) can greatly complicate the course of heart failure (HF). Although recent trials have indicated the nonsuperiority of a rhythm control strategy in the general population with AF, this may not apply to patients with HF. We feel strongly that AF be treated aggressively in patients with HF, defaulting toward an initial rhythm control strategy, to avoid the hemodynamic detriment of irregular rapid ventricular response and the development of tachycardia-related myopathy. The index episode is treated with cardioversion and antiarrhythmic therapy. If significant benefit is demonstrated, the rhythm control strategy is maintained, to the point of catheter ablation for AF if necessary. If there is no change in cardiac performance or symptoms after cardioversion, strict rate control is enforced, to the point of atrioventricular node ablation and pacing if necessary.

AB - The development of atrial fibrillation (AF) can greatly complicate the course of heart failure (HF). Although recent trials have indicated the nonsuperiority of a rhythm control strategy in the general population with AF, this may not apply to patients with HF. We feel strongly that AF be treated aggressively in patients with HF, defaulting toward an initial rhythm control strategy, to avoid the hemodynamic detriment of irregular rapid ventricular response and the development of tachycardia-related myopathy. The index episode is treated with cardioversion and antiarrhythmic therapy. If significant benefit is demonstrated, the rhythm control strategy is maintained, to the point of catheter ablation for AF if necessary. If there is no change in cardiac performance or symptoms after cardioversion, strict rate control is enforced, to the point of atrioventricular node ablation and pacing if necessary.

UR - http://www.scopus.com/inward/record.url?scp=33746307847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746307847&partnerID=8YFLogxK

U2 - 10.1007/s11936-006-0053-3

DO - 10.1007/s11936-006-0053-3

M3 - Article

C2 - 17038272

AN - SCOPUS:33746307847

VL - 8

SP - 325

EP - 333

JO - Current Treatment Options in Cardiovascular Medicine

JF - Current Treatment Options in Cardiovascular Medicine

SN - 1092-8464

IS - 4

ER -